Market Overview

Glucose Health, Inc. Appoints Respected Nutrition Scientist As Advisor


WEST PALM BEACH, Fla., Jan. 29, 2015 /PRNewswire/ -- Glucose Health, Inc. (OTC: GLUC) ("Company") today announced the appointment of Chandrasekhar Mallangi, Ph.D., as an advisor to the Company, through the signing of an Agreement with CMS Consulting LLC, of which Dr. Mallangi is a principal.

Glucose Health, Inc. products serve the growing market of persons aware of the dangers of Type 2 diabetes and interested in proactive blood sugar health solutions. Dr. Mallangi will provide technical support including future development of additional dietary products derived from the Company's proprietary Glucose Health formula.   

Dr. Mallangi spent more than 3 decades as a scientist and advisor to multinational companies in the development of nutritional products including health care and performance nutrition products, juices and tea-based beverages.

Dr. Mallangi earned a Ph.D. in Food Science from Oregon State University and an M.S in Dairy Science from Kansas State University

Dr. Mallangi is a member of the Institute of Food Technologists and a member of the American Society for Parenteral and Enteral Nutrition

Additionally, Dr. Mallangi is the credited inventor or co-inventor for patents in the area of food nutrition, awarded by the United States Patent and Trademark Office to Nestec, SA and Societe Des Produits Nestle S.A.; subsidiaries of Nestle, SA (OTC: NSRGY) of Vevey, Switzerland.

About Glucose Health, Inc.

Glucose Health, Inc. dietary products engage the large and growing market of consumers aware of the seriousness of Type 2 diabetes and proactively seeking natural blood sugar health solutions. The Centers for Disease Control and Prevention now estimates 2 in 5 adults - 40% of Americans - will develop Type 2 diabetes at some point in their lifetime.  Glucose Health, Inc. dietary products are marketed to pharmacy retailers, through online marketplaces and via the Company's product website

For further information about Glucose Health, Inc., please call 1-888-987-6315 (press 1).

Glucose Health, Inc.





To view the original version on PR Newswire, visit:

SOURCE Glucose Health, Inc.

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at